Targeted nanoparticle treatment for breast cancer stem cells

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500047C
Awardee
Awarding agency
Obligated
$299,813

Award facts

Opportunity
  • PHS201501 Solicitation number
Contract value 100% obligated
$299,813.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 8 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Lawrence, KS 66047, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 · Targeted nanoparticle treatment for breast cancer stem cells period of performance 09/18/2015-06/17/2016 $0
Original award $299,813

About this award

This is a $299,813 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Hylapharm LLC, a self-certified small disadvantaged business, under the SBIR Program Phase I. The contract is for the development of "Targeted Nanoparticle Treatment for Breast Cancer Stem Cells." This contract has a Total Small Business set-aside designation. The contract has an ultimate completion date of September 17, 2016.

Quick answers

Who was awarded contract HHSN261201500047C?

HHSN261201500047C was awarded to Hylapharm LLC by National Cancer Institute (National Institutes of Health) on September 18, 2015.

How much is contract HHSN261201500047C worth?

The government has obligated $299,813 on HHSN261201500047C.

Was contract HHSN261201500047C competed?

The extent of competition for HHSN261201500047C was full and open competition after exclusion of sources. The government received 8 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award